Literature DB >> 7666815

Microscopic findings of the nail-fold capillaries--dependence on menopausal status and hormone replacement therapy.

W Haenggi1, H R Linder, M H Birkhaeuser, H Schneider.   

Abstract

The aim of our controlled study was to evaluate peripheral microcirculation at the level of the nail-fold capillaries in relation to menopause status and postmenopausal hormone replacement therapy (HRT). A total of 105 postmenopausal women were randomly allocated to three different HRT groups of equal size. A fourth group of 35 similar healthy volunteers served as controls. HRT was either peroral or transdermal 17-beta-oestradiol with cyclic addition of dydrogesterone or 2.5 mg Tibolone (Org OD 14) in a daily peroral dose. Morphological parameters such as capillary diameters, loop width, papillary width and capillary density, measured by video-capillaroscopy at the nail-fold, were unaffected in early menopause and also under HRT. A significant decrease of capillary blood flow velocity (P < 0.001) could be demonstrated in postmenopausal (n = 41, v = 0.53 +/- 0.16 mm/s) as compared to premenopausal women (n = 37, v = 0.65 +/- 0.15 mm/s). HRT resulted in an increase of capillary blood flow velocity in the nail-fold after 6 and 12 months leading to an increase in capillary blood flow in the order of 20%-30% of the initial values, and was independent of the type of HRT.

Entities:  

Mesh:

Year:  1995        PMID: 7666815     DOI: 10.1016/0378-5122(95)00911-4

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  2 in total

Review 1.  Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.

Authors:  R H Foster; J A Balfour
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

2.  The determinants of periorbital skin ageing in participants of a melanoma case-control study in the U.K.

Authors:  M Suppa; F Elliott; J S Mikeljevic; Y Mukasa; M Chan; S Leake; B Karpavicius; S Haynes; E Bakker; K Peris; J H Barrett; D T Bishop; J A Newton Bishop
Journal:  Br J Dermatol       Date:  2011-11       Impact factor: 9.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.